SUXAMETHONIUM


Synonyms	Anectine Quelicin Succinylcholine Succinylcholine cation Succinylcholine ion Sucostrin Suxamethonium Suxamethonium cation Suxamethonium ion
Status
Molecule Category	Free-form
ATC	M03AB01
UNII	J2R869A8YF
EPA CompTox	DTXSID7048455


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	AXOIZCJOOAYSMI-UHFFFAOYSA-N
Smiles	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
InChI	InChI=1S/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C14H30N2O4+2
Molecular Weight	290.4
AlogP	0.27
Hydrogen Bond Acceptor	4.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	9.0
Polar Surface Area	52.6
Molecular species	NEUTRAL
Aromatic Rings	0.0
Heavy Atoms	20.0

Cross References

Resources	Reference
ChEBI	45652
ChEMBL	CHEMBL703
DrugBank	DB00202
DrugCentral	2489
FDA SRS	J2R869A8YF
Human Metabolome Database	HMDB0014347
Guide to Pharmacology	4004
KEGG	C07546
PDB	SCK
PharmGKB	PA451522
SureChEMBL	SCHEMBL41537
ZINC	ZINC000001530820

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).